Sugar tracer reveals brain tumor secrets in new study

NCT ID NCT01668082

Recruiting now Knowledge-focused Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study gives patients with a new brain mass a safe, non-radioactive sugar tracer before surgery to see how their tumor uses energy. Researchers will analyze the tumor tissue and compare it with MRI scans to find patterns that could help identify aggressive tumor cells. The goal is to improve understanding of brain tumors, not to test a new treatment. About 40 people of any age are being recruited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 13C-glucose (a non-radioactive, naturally occurring isotope of glucose)
What this could lead to: If successful, this could lead to better ways to identify aggressive tumor cells without invasive biopsies, improving diagnosis and treatment planning.
What could go wrong: This is an early observational study with only 40 participants, so results may not apply to all brain tumor types. It is designed to gather knowledge, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN MASS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN MASS

Contacts and locations

Locations

University of Texas Southwestern
RECRUITING

Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.